Exosomes derived from human adipose mesenchymal stem cells inhibits fibrosis and treats oral submucous fibrosis via the miR-181a-5p/Smad2 axis.
Authors:
Preprint
- 28 February 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: Oral submucous fibrosis (OSF) is a chronic disease with carcinogenic tendency that poses a non-negligible threat to human health. Exosomes derived from human adipose mesenchymal stem cells (ADSC-Exo) reduces visceral and cutaneous fibroses, but theirrole in OSF has received little attention. The aim of this studywas to investigate the effects of ADSC-Exo on OSFand elucidate the mechanism. Methods: In brief, ADSCs were extracted from adipose tissues and subjected to flow cytometry and induction culture. Fibroblasts were isolated from human buccal mucosa and subjected to immunofluorescence. Myofibroblasts were obtained from fibroblasts induced by arecoline and identified. Immunofluorescence assay confirmed that myofibroblasts could take up ADSC-Exo. The effects of ADSC-Exo on the proliferative and migratory capacities of myofibroblasts were examined using the Cell Counting Kit-8 and scratch assay. Real-time quantitative polymerase chain reaction (qPCR) was performed to evaluate mothers against decapentaplegic homolog 2 (Smad2), Smad3, Smad7, collagen type 1 (Col1),Col3, alpha smooth muscle actin (α-SMA), fibronectin, and vimentin. Western blotting was performed to detect phospho (p)-Smad2, Smad2, p-Smad2/3, Smad2/3, Smad7, Col1, Col3, α-SMA, fibronectin, and vimentin. Furthermore, the dual-luciferase reporter assay was performed to prove that miR-181a-5p in ADSC-Exo directly inhibited the expression of Smad2mRNA to regulate the transforming growth factor beta (TGF-β)pathway. We also performed qPCR and western blotting to verify the results. Results: ADSC-Exo could promote the proliferation and migration of myofibroblasts, reduce the expressions of p-smad2, Smad2, p-smad2/3, Smad2/3, Col1, αSMA, fibronectin, and vimentin and elevated the levels of Smad7 and Col3. In addition, miR-181a-5p was highly expressed in ADSC-Exo and bound to the 3'-untranslated region of Smad2. ADSC-Exo enriched with miR-181a-5p reduced collagen production in myofibroblasts and modulated the TGF-β pathway. Conclusions: ADSC-Exo promoted the proliferative and migratory capacities of myofibroblasts and inhibited collagen deposition and trans-differentiation of myofibroblasts in vitro. miR-181a-5p in exosomes targets Smad2 to regulate the TGF-β pathway in myofibroblasts. ADSC-Exo perform antifibrotic actions through the miR-181a-5p/Smad2 axis and may be a promising clinical treatment for OSF. Trial registration: Not applicableKeywords
All Related Versions
This publication has 53 references indexed in Scilit:
- TGF-β signal transduction spreading to a wider field: a broad variety of mechanisms for context-dependent effects of TGF-βCell and tissue research, 2011
- TNF‐α induces matrix metalloproteinase‐9 expression in A549 cells: Role of TNFR1/TRAF2/PKCα‐dependent signaling pathwaysJournal of Cellular Physiology, 2010
- Nucleocytoplasmic shuttling of Smad proteinsCell Research, 2008
- Phospho-control of TGF-β superfamily signalingCell Research, 2008
- The impact of microRNAs on protein outputNature, 2008
- Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failureMolecular Biology Reports, 2008
- Common and unique mechanisms regulate fibrosis in various fibroproliferative diseasesJournal of Clinical Investigation, 2007
- Molecular pathogenesis of oral submucous fibrosis – a collagen metabolic disorderJournal of Oral Pathology & Medicine, 2005
- Role of areca nut in the causation of oral submucous fibrosis: a case‐control study in PakistanJournal of Oral Pathology & Medicine, 1994
- An endotoxin-induced serum factor that causes necrosis of tumors.Proceedings of the National Academy of Sciences, 1975